GLP-1 researcher Daniel Drucker links to findings on Lilly's experimental retatrutide and sleep apnea. Details are at the link.
Recap by typeshit. Post by Daniel J Drucker on X.
Early uptake of the Wegovy pill outpaced injectable incretin weight loss drugs at a similar stage, HealthDay reported on Oct. 22.
Leftover food can't tell researchers whether someone stopped eating from fullness or from feeling sick, and Medical Xpress explains why that gap matters.
Moss says he once believed GLP-1s caused far more muscle loss than ordinary calorie cutting. He now says he got that wrong.
Topol points to neoantigens, the proteins or peptides on cancer cell surfaces, as the base of personalized cancer therapies.
The bank points to the international Oral Wegovy rollout and coming trial results as near-term catalysts, while flagging its Q3 earnings view.
She weighs whether the pop-up clinics spreading lately are a good thing for weight loss patients and for medicine overall.
Loading…